October Sees $4B+ in M&A Deals as Health Stocks Enter Earnings Season and Wait on Election and Rate Moves. Longboard Acquistion Over $2.6B

Week Ending October 25th, 2024

• Biotech: 4 Transactions (1 IPO, 1 Follow-On, 1 PIPE, and 1 RD) totaling just over $400 Million

• Med Tech: 1 Transaction (1 Follow-On) totaling just under $50 Million

2024 YTD:

• 229 Biotech transactions totaling just under $41 Billion vs. 2023 YTD: 149 Biotech transactions totaling just over $22 Billion

• 15 Med Tech transactions totaling just over $1.5 Billion vs. 2023 YTD: 16 Med Tech transactions totaling just over $1 Billion

Private Transactions:

• Biotech: 226 US Transactions / 91 European Transactions

• Med Tech: 148 US Transactions / 50 European Transactions

October M&A:

• AbbVie acquired Aliada Therapeutics for $1.4B

• Lundbeck acquired Longboard Pharmaceuticals for $2.6B or $60/share